Literature DB >> 17055710

Effect of selected fluorinated drugs in a "ringing" gel on rheological behaviour and skin permeation.

Sonja Höller1, Claudia Valenta.   

Abstract

The purpose of the present study was to investigate the influence of different drugs exhibiting different solubility on the viscoelastic properties and on the skin diffusion profile of a ringing gel. In a preliminary rheology study with the placebo gel predominating elastic properties were confirmed and a temperature influence was indicated. Fluconazole, fludrocortisone-acetate, flumethasone-pivalate, flutamide and flufenamic-acid each 1% (w/w) were incorporated into the preparation and oscillatory measurements were performed at temperatures of 25, 28, 32 and 37 degrees C. In all drug containing formulations a high elastic G' value predominated the viscous G'' value. The highest G' value could be obtained with the incorporated flumethasone-pivalate. Additionally in almost all cases the G' values decreased with increasing temperature compared to the placebo gel. Additionally in vitro standard diffusion experiments using Franz-type cells and porcine skin were performed. Following rank order of the cumulative drug release after 48 h was obtained: fluconazole>flufenamic-acid>flumethasone-pivalate>flutamide>fludrocortisone-acetate. Furthermore an excellent chemical stability of all incorporated drugs was confirmed over 10 weeks.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17055710     DOI: 10.1016/j.ejpb.2006.08.019

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  2 in total

1.  Lamellar liquid crystalline phases for cutaneous delivery of Paclitaxel: impact of the monoglyceride.

Authors:  Jaclyn M Hosmer; Alexandre A Steiner; Luciana B Lopes
Journal:  Pharm Res       Date:  2012-11-08       Impact factor: 4.200

2.  Semi-solid Sucrose Stearate-Based Emulsions as Dermal Drug Delivery Systems.

Authors:  Victoria Klang; Julia C Schwarz; Nadejda Matsko; Elham Rezvani; Nivine El-Hagin; Michael Wirth; Claudia Valenta
Journal:  Pharmaceutics       Date:  2011-05-30       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.